C3 Ventures — 2016 Investments

1 investments dated 2016 · listed companies and verified rows first · show all

CB Therapeuticscbthera.com inJul 2016

CB Therapeutics builds a yeast platform for biosynthesis of molecules including psychedelics, cannabis, and alkaloids that are difficult to source through conventional methods.

AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US

Sher Butt(CEO)in Jacob Vogan(Founder)inJason (Zhen) Qi(Founder)inGuoliang Yu(Executive Officer, Director)Stephanie Elliot(Admin)Thanos Karavokiris(Vice President Operations)

Co-investorsaVenture James Beshara Fund Metaplanet Pioneer Y Combinator Apeiron Venture Capital +7 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.